Clinical Phenotypes in Patients With Type 2 Diabetes Mellitus: Characteristics, Cardiovascular Outcomes and Treatment Strategies

被引：0
作者：
Pishoy Gouda
Sijia Zheng
Tricia Peters
Marat Fudim
Varinder Kaur Randhawa
Justin Ezekowitz
Thomas A. Mavrakanas
Nadia Giannetti
Michael Tsoukas
Renato Lopes
Abhinav Sharma
机构：
[1] University of Alberta,Department of Medicine, Division of Cardiology
[2] McGill University Health Centre,Department of Medicine
[3] Lady Davis Institute for Medical Research,Centre for Clinical Epidemiology
[4] The Jewish General Hospital,Division of Endocrinology, Department of Medicine
[5] McGill University,Department of Medicine, Duke Clinical Research Institute
[6] Duke University Medical Center,Department of Cardiovascular Medicine, Kaufman Center for Heart Failure and Recovery
[7] Cleveland Clinic Foundation,Division of Nephrology, Department of Medicine
[8] Canadian VIGOUR Centre,Division of Endocrinology
[9] McGill University Health Centre and Research Institute,undefined
[10] McGill University Health Centre,undefined
来源：
Current Heart Failure Reports | 2021年 / 18卷
关键词：
Diabetes; Phenotypes; Cardiovascular outcomes;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：253 / 263
页数：10
相关论文
共 182 条
  • [1] Einarson TR(2018)Prevalence of cardiovascular disease in type 2 diabetes: a systematic literature review of scientific evidence from across the world in 2007–2017 Cardiovasc Diabetol 17 83-1418
  • [2] Acs A(2017)Mortality and cardiovascular disease in type 1 and type 2 diabetes N Engl J Med 376 1407-591
  • [3] Ludwig C(2020)Pharmacologic glycemic management of type 2 diabetes in adults: 2020 update Can J Diabetes 44 575-323
  • [4] Panton UH(2020)2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: the Task Force for diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and the European Association for the Study of Diabetes (EASD) Eur Heart J 41 255-1956
  • [5] Rawshani A(2013)Agreement among cardiovascular disease risk calculators Circulation 127 1948-116
  • [6] Rawshani A(2017)Machine learning and data mining methods in diabetes research Comput Struct Biotechnol J 15 104-291
  • [7] Franzén S(2011)Identifying groups: a comparison of methodologies Journal of Data Science 9 271-1335
  • [8] Eliasson B(2013)Alogliptin after acute coronary syndrome in patients with type 2 diabetes N Engl J Med 369 1327-1326
  • [9] Svensson A-M(2013)Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus N Engl J Med 369 1317-1166
  • [10] Miftaraj M(2019)Effect of linagliptin vs glimepiride on major adverse cardiovascular outcomes in patients with type 2 diabetes: the CAROLINA randomized clinical trial JAMA 322 1155-242
12345678910